DNV-II Impurity 1 | CAS 1005324-46-8 - Request Quote
DNV-II Impurity 1
| SZ CAT No: | SZ-D045014 |
| CAS No | 1005324-46-8 |
| Mol.F. | C25H35N3O7S |
| Mol.Wt. | 521.6 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
DNV-II Impurity 1 is chemically Tert-butyl ((2R,3S)-3-hydroxy-4-((N-isobutyl-4-nitrophenyl)sulfonamido)-1-phenylbutan-2-yl)carbamate. DNV-II Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. DNV-II Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Darunavir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1005324-46-8
Purchase 1005324-46-8
Order 1005324-46-8
Enquire 1005324-46-8
price of 1005324-46-8
1005324-46-8 Supplier
1005324-46-8 Manufacturer
1005324-46-8 Exporter
buy high quality DNV-II Impurity 1
Purchase DNV-II Impurity 1
DNV-II Impurity 1 suppliers
DNV-II Impurity 1 manufacturers
DNV-II Impurity 1 price
Order DNV-II Impurity 1
Enquire DNV-II Impurity 1
DNV-II Impurity 1 cost
DNV-II Impurity 1 Supplier
DNV-II Impurity 1 Distributor
DNV-II Impurity 1 for Method Validation
Darunavir Reference Standard
DNV-II Impurity 1 for ANDA Filing
DNV-II Impurity 1 for Forced Degradation Studies
DNV-II Impurity 1 Identification Standards
DNV-II Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


